Viewing Study NCT04501718


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2026-03-15 @ 2:37 AM
Study NCT ID: NCT04501718
Status: RECRUITING
Last Update Posted: 2024-10-15
First Post: 2020-08-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Sponsor: Beijing Sanbo Brain Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Medulloblastoma View
Keywords: